Evaluation of lauroyl-gemcitabine-loaded hydrogel efficacy in glioblastoma rat models

被引:36
作者
Bastiancich, Chiara [1 ,2 ]
Lemaire, Laurent [2 ,3 ]
Bianco, John [1 ]
Franconi, Florence [2 ,3 ]
Danhier, Fabienne [1 ]
Preat, Veronique [1 ]
Bastiat, Guillaume [2 ]
Lagarce, Frederic [2 ,4 ]
机构
[1] Catholic Univ Louvain, Adv Drug Delivery & Biomat, Louvain Drug Res Inst, Ave Mounier, B-1200 Brussels, Belgium
[2] UBL, UNIV Angers, Micro & Nanomed Translat MINT, INSERM U1066,CNRS UMR 6021, Angers, France
[3] UBL, PRISM Plateforme Rech Imagerie & Spect Multimoda, PRISM Icat Angers, Angers, France
[4] Angers Univ Hosp, CHU Angers, Pharm Dept, Angers, France
关键词
glioblastoma; hydrogel; lipid nanocapsules; local delivery; MRI; rat; resection; LIPID NANOCAPSULES; LOCAL CHEMOTHERAPY; GLIADEL WAFERS; BRAIN; RADIOTHERAPY; CARMUSTINE; RESECTION; DRUG; SPECTROSCOPY; TEMOZOLOMIDE;
D O I
10.2217/nnm-2018-0057
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Anticancer drug-loaded hydrogels are a promising strategy for the local treatment of incurable brain tumors such as glioblastoma (GBM). Recently, we demonstrated the efficacy of lauroyl-gemcitabine lipid nanocapsule hydrogel (GemC(12)-LNC) in a U-87 MG xenograft orthotopic mouse model. In this study, we developed a reliable and reproducible surgical procedure to resect orthotopic GBM tumors in rats. GemC(12)-LNC hydrogel integrity was tested after brain administration in rats and its anti-tumor efficacy was tested on a 9L syngeneic orthotopic model. Results: We demonstrated that LNC integrity is maintained at least for one week after local administration of GemC(12)-LNC. GemC(12)-LNC was able to delay the formation of recurrences in 9L tumor-bearing resected rats, demonstrating the efficacy of this nanomedicine hydrogel in this preclinical model. Conclusion: Our results confirm that GemC(12)-LNC, a hydrogel uniquely formed by a nanocarrier and a cytotoxic drug, could be a promising and safe delivery tool for the local treatment of operable GBM tumors. [GRAPHICS] .
引用
收藏
页码:1999 / 2013
页数:15
相关论文
共 39 条
[1]   Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection [J].
Akbar, Umar ;
Jones, Terreia ;
Winestone, Jon ;
Michael, Madison ;
Shukla, Atul ;
Sun, Yichun ;
Duntsch, Christopher .
JOURNAL OF NEURO-ONCOLOGY, 2009, 94 (02) :203-212
[2]   The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence [J].
Auffinger, Brenda ;
Spencer, Drew ;
Pytel, Peter ;
Ahmed, Atique U. ;
Lesniak, Maciej S. .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (07) :741-752
[3]   Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas [J].
Barth, Rolf F. ;
Kaur, Balveen .
JOURNAL OF NEURO-ONCOLOGY, 2009, 94 (03) :299-312
[4]   Injectable nanomedicine hydrogel for local chemotherapy of glioblastoma after surgical resection [J].
Bastiancich, C. ;
Bianco, J. ;
Vanvarenberg, K. ;
Ucakar, B. ;
Joudiou, N. ;
Gallez, B. ;
Bastiat, G. ;
Lagarce, F. ;
Preat, V. ;
Danhier, F. .
JOURNAL OF CONTROLLED RELEASE, 2017, 264 :45-54
[5]   Lauroyl-gemcitabine-loaded lipid nanocapsule hydrogel for the treatment of glioblastoma [J].
Bastiancich, C. ;
Vanvarenberg, K. ;
Ucakar, B. ;
Pitorre, M. ;
Bastiat, G. ;
Lagarce, F. ;
Preat, V. ;
Danhier, F. .
JOURNAL OF CONTROLLED RELEASE, 2016, 225 :283-293
[6]   Gemcitabine and glioblastoma: challenges and current perspectives [J].
Bastiancich, Chiara ;
Bastiat, Guillaume ;
Lagarce, Frederic .
DRUG DISCOVERY TODAY, 2018, 23 (02) :416-423
[7]   On glioblastoma and the search for a cure: where do we stand? [J].
Bianco, John ;
Bastiancich, Chiara ;
Jankovski, Aleksander ;
des Rieux, Anne ;
Preat, Veronique ;
Danhier, Fabienne .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (13) :2451-2466
[8]   Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice [J].
Bianco, John ;
Bastiancich, Chiara ;
Joudiou, Nicolas ;
Gallez, Bernard ;
des Rieux, Anne ;
Danhier, Fabienne .
JOURNAL OF NEUROSCIENCE METHODS, 2017, 284 :96-102
[9]  
Bota Daniela A, 2007, Ther Clin Risk Manag, V3, P707
[10]   Intracranial glioblastoma models in preclinical neuro-oncology: neuropathological characterization and tumor progression [J].
Candolfi, Marianela ;
Curtin, James F. ;
Nichols, W. Stephen ;
Muhammad, A. K. M. G. ;
King, Gwendalyn D. ;
Pluhar, G. Elizabeth ;
McNiel, Elizabeth A. ;
Ohlfest, John R. ;
Freese, Andrew B. ;
Moore, Peter F. ;
Lerner, Jonathan ;
Lowenstein, Pedro R. ;
Castro, Maria G. .
JOURNAL OF NEURO-ONCOLOGY, 2007, 85 (02) :133-148